Skip to main content

Advertisement

SpringerLink
Log in

Cyclooxygenase inhibitors and thalidomide ameliorate vincristine-induced hyperalgesia in rats

  • Original Article
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

In this study ibuprofen (50.0 mg/kg, i.p.), rofecoxib (10.0 mg/kg, i.p.) and thalidomide (50.0 mg/kg, oral) were shown to prevent vincristine-induced mechanical hyperalgesia. Sprague-Dawley rats were injected every other day with vincristine (0.1 mg/kg) over 13 days. The animals were cotreated daily with vehicle (saline), ibuprofen, rofecoxib or thalidomide throughout the period of vincristine treatment. Mechanical withdrawal threshold to punctuate and radiant heat stimuli were determined prior to and then on alternate days throughout the treatment period. Vincristine vehicle-treated animals developed marked mechanical hyperalgesia from day 5 of chemotherapy and this lasted until the end of the experiment. Thermal thresholds were not altered by the administration of vincristine vehicle. Animals in the vincristine vehicle group neither gained nor lost weight during the treatment period. All three active drugs showed an antihyperalgesic effect on the responses to mechanical stimulation of the hind paw that was significant from day 5 for ibuprofen and thalidomide and from day 7 for rofecoxib. Thermal thresholds increased after the administration of both the NSAIDs and thalidomide. Rofecoxib was the only drug to show any beneficial effect in protecting the animals from failure to gain body weight.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Adam-Klages S, Adam D, Wiegmann K, Struve S, Waldemar K, Schneider-Mergener J, Kronke M (1996) FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 86:937–947

    Article  CAS  PubMed  Google Scholar 

  2. Aley KO, Reichling DB, Levine JD (1996) Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans. Neuroscience 73:259–265

    Article  CAS  PubMed  Google Scholar 

  3. Allan SM (2000) The role of pro- and antiinflammatory cytokines in neurodegeneration. Ann N Y Acad Sci 917:84–93

    CAS  PubMed  Google Scholar 

  4. Bao L, Zhu Y, Elhassan AM, Wu Q, Xiao B, Zhu J, Lindgren JU (2001) Adjuvant-induced arthritis: IL-1 beta, IL-6 and TNF-alpha are up- regulated in the spinal cord. Neuroreport 12:3905–3908

    Article  CAS  PubMed  Google Scholar 

  5. Bennett GJ (1999) Does a neuroimmune interaction contribute to the genesis of painful peripheral neuropathies? Proc Natl Acad Sci U S A 96:7737–7738

    Article  CAS  PubMed  Google Scholar 

  6. Bennett GJ (2000) A neuroimmune interaction in painful peripheral neuropathy. Clin J Pain 16:S139–S143

    CAS  PubMed  Google Scholar 

  7. Bennett GJ, Xie YK (1988) A peripheral mononeuropathy in rat that produces disorder of pain sensation like those seen in man. Pain 33:87–107

    Article  CAS  PubMed  Google Scholar 

  8. Bove SE, Calcaterra SL, Brooker RM, Huber CM, Guzman RE, Juneau PL, Schrier DJ, Kilgore KS (2003) Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthritis Cartilage 11:821–830

    Article  CAS  PubMed  Google Scholar 

  9. Bradley WG, Lassman LP, Pearce GW, Walton JN (1970) The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies. J Neurol Sci 10:107–131

    Article  CAS  PubMed  Google Scholar 

  10. Breitbart W, McDonald MV, Rosenfeld B, Passik SD, Hewitt D, Thaler H, Portenoy RK (1996) Pain in ambulatory AIDS patients. I: Pain characteristics and medical correlates. Pain 68:315–321

    Article  CAS  PubMed  Google Scholar 

  11. Calabrese L, Fleischer AB (2000) Thalidomide: current and potential clinical applications. Am J Med 108:487–495

    Article  CAS  PubMed  Google Scholar 

  12. Casey EB, Jellife AM, Le Quesne PM, Millet YL (1973) Vincristine neuropathy. Clinical and electrophysiological observations. Brain 96:69–86

    CAS  PubMed  Google Scholar 

  13. Chacur M, Milligan ED, Gazda LS, Armstrong C, Wang H, Tracey KJ, Maier SF, Watkins LR (2001) A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats. Pain 94:231–244

    Article  CAS  PubMed  Google Scholar 

  14. Chan C-C, Boyce S, Charleson S, Cromlish W, Ethier D, Evans J, Ford-Hutchinson WA, Forrest MJ, Gauthier JY, Gordon R, Gresser M, Guay J, Kargman S, Kennedy BLY, Leger S, Mancini J, O’Neill GP, Ouellet M, Patrick D, Percival MD, Perrier H, Prasit P, Rodger I, Tagari P, Therien M, Vickers P, Visco P, Wang Z, Webb J, Wong E, Xu L-J, Young RN, Zamboni R, Riendieau D (1999) Rofecoxib [Vioxx, MK-0966; 4-(4’-Methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J Pharmacol Exp Ther 290:551–560

    CAS  PubMed  Google Scholar 

  15. Cornblath DR, McArthur JC (1988) Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology 38:794–796

    CAS  PubMed  Google Scholar 

  16. Dougherty PM, Cata JP, Cordella JV, Burton A, Weng H-R (2004) Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 109:132–142

    Article  CAS  PubMed  Google Scholar 

  17. Dougherty PM, Cordella JV, Weng HR (2001) Chemotherapy-induced hypersensitivity is accompanied by a decrease in spontaneous locomotor activity. Neurosci Abstr 27

  18. Dyck PJ, Dyck PJB, Velosa JA, Larson TS, O’Brien PC, The Nerve Growth Factor Study Group (2000) Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy. Diabetes Care 23:510–517

    CAS  PubMed  Google Scholar 

  19. Ferrua B, Doglio MS, Shaw A, Sonthonnax S, Limouse M, Schaffar L (1990) Stimulation of human interleukin 1 production and specific mRNA expression by microtubule-disrupting drugs. Cell Immunol 131:391–397

    CAS  PubMed  Google Scholar 

  20. Finck BN, Johnson RW (1997) Anorexia, weight loss and increased plasma interleukin-6 caused by chronic intracerebroventricular infusion of interleukin-1b in the rat. Brain Res 761:333–337

    Article  CAS  PubMed  Google Scholar 

  21. Garrison CJ, Dougherty PM, Carlton SM (1994) GFAP expression in lumbar spinal cord of naive and neuropathic rats treated with MK-801. Exp Neurol 129:237–243

    Article  CAS  PubMed  Google Scholar 

  22. Gelber DA, Pfeifer MA, Broadstone VL, Munster EW, Peterson M, Arezzo JC, Shamoon H, Zeidler A, Clements R, Greene DA, Porte D Jr, Laudadio C, Bril V (1995) Components of variance for vibratory and thermal threshold testing in normal and diabetic subjects. J Diabetes Comp 9:170–176

    Article  CAS  Google Scholar 

  23. George A, Marziniak M, Schafers M, Toyka KV, Sommer C (2000) Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-alpha, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin. Pain 88:267–275

    Article  CAS  PubMed  Google Scholar 

  24. Green SV, Donoso JA, Heller-Bettinger IE, Samson FE (1977) Axonal transport disturbances in vincristine-induced peripheral neuropathy. Ann Neurol 1:255–262

    CAS  PubMed  Google Scholar 

  25. Hargreaves KM, Dubner R, Brown F, Flores C, Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77–88

    Article  CAS  PubMed  Google Scholar 

  26. Holland JF, Scharlau C, Gailani S, Krant MJ, Olson KB, Horton J, Shnider BI, Lynch JJ, Owens A, Carbone PP, Colsky J, Grob D, Miller SP, Hall TC (1973) Vincristine treatment of advanced cancer: a cooperative study of 392 cases. Cancer Res 33:1258–1264

    CAS  PubMed  Google Scholar 

  27. Honore P, Menning PM, Rogers SD, Nichols ML, Mantyh PW (2000) Neurochemical plasticity in persistent inflammatory pain. Prog Brain Res 129:357–363

    Article  CAS  PubMed  Google Scholar 

  28. Kajander KC, Bennett GJ (1992) Onset of a painful neuropathy in rat: a partial and differential deafferentation and spontaneous discharge in AB and Ad primary afferent neurons. J Neurophysiol 68:734–744

    CAS  PubMed  Google Scholar 

  29. Keifer JA, Guttridge DC, Ashburner BP, Baldwin AS (2001) Inhibition of NF-kB activity by thalidomide through suppression of IkB kinase activity. J Biol Chem 276:22382–22387

    Article  CAS  PubMed  Google Scholar 

  30. Kim SH, Chung JM (1992) An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50:355–364

    Article  CAS  PubMed  Google Scholar 

  31. Kimura T, Iwase M, Kondo G, Watanabe H, Ohashi M, Ito D, Nagumo M (2003) Suppressive effect of selective cyclooxygenase-2 inhibitor on cytokine release in human neutrophils. Int Immunopharmacol 3:1519–1528

    Article  CAS  PubMed  Google Scholar 

  32. Laird JM, Bennett GJ (1993) An electrophysiological study of dorsal horn neurons in the spinal cord of rats with an experimental peripheral neuropathy. J Neurophysiol 69:2072–2085

    CAS  PubMed  Google Scholar 

  33. Lashbrook JM, Ossipov MH, Hunter JC, Raffa RB, Tallarida RJ, Porreca F (1999) Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX-1 and COX-2 inhibitors in nerve injured rats. Pain 82:65–72

    Article  CAS  PubMed  Google Scholar 

  34. Leem JG, Bove GM (2002) Mid-axonal tumor necrosis factor-alpha induces ectopic activity in a subset of slowly conducting cutaneous and deep afferent neurons. J Pain 3:45–49

    Article  PubMed  Google Scholar 

  35. Lindholm D, Heumann R, Meyer M, Thoenen H (1987) Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 30:658–659

    Article  Google Scholar 

  36. Lokensgard RJ, Hu S, van Fenema EM, Sheng WS, Peterson PK (2000) Effect of thalidomide on chemokine production by human microglia. J Infect Dis 182:983–987

    Article  CAS  PubMed  Google Scholar 

  37. Ma W, Du W, Eisenach JC (2002) Role for both spinal cord COX-1 and COX- 2 in maintenance of mechanical hypersensitivity following peripheral nerve injury. Brain Res 937:94–99

    Article  CAS  PubMed  Google Scholar 

  38. Ma W, Eisenach JC (2002) Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain. Eur J Neurosci 15:1037–1047

    Article  PubMed  Google Scholar 

  39. Mantovani G, Maccio A, Madeddu C (2001) Managing cancer-related anorexia/cachexia. Drugs 61:499–514

    CAS  PubMed  Google Scholar 

  40. Mazario J, Gaitan G, Herrero JF (2001) Cyclooxygenase-1 versus cyclooxygenase-2 inhibitors in the induction of antinociception in rodent withdrawal reflexes. Neuropharmacology 40:937–946

    Article  CAS  PubMed  Google Scholar 

  41. Meade EA, Smith WL, DeWitt DL (1993) Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isoenzymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 268:6610–6614

    CAS  PubMed  Google Scholar 

  42. Moos PJ, Muskardin DT, Fitzpatrick FA (1999) Effect of taxol and taxotere on gene expression in macrophages: induction of the prostaglandin H synthase-2 isoenzyme. J Immunol 162:467–473

    CAS  PubMed  Google Scholar 

  43. Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G (1993) Thalidomide exerts its inhibitory action on tumor necrosis factor a by enhancing mRNA degradation. J Exp Med 177:1675–1680

    Article  CAS  PubMed  Google Scholar 

  44. Morioka N, Inoue A, Hanada T, Kumagai K, Takeda K, Ikoma K, Hide I, Tamura Y, Shiomi H, Dohi T, Nakata Y (2002) Nitric oxide synergistically potentiates interleukin-1b-induced increase of cyclooxygenase-2 mRNA levels, resulting in the facilitation of substance P release from primary afferent neurons: involvement of cGMP-independent mechanisms. Neuropharmacology 43:868–876

    Article  CAS  PubMed  Google Scholar 

  45. Neumann S, Doubell TP, Leslie T, Woolf CJ (1996) Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature 384:360–364

    Article  CAS  PubMed  Google Scholar 

  46. Nozaki-Taguchi N, Chaplan SR, Higuera S, Ajakwe RC, Yaksh TL (2001) Vincristine-induced allodynia in the rat. Pain 93:69–76

    Article  CAS  PubMed  Google Scholar 

  47. Okamoto K, Martin DP, Schmelzer JD, Mitsui Y, Low PA (2001) Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Exp Neurol 169:386–391

    Article  CAS  PubMed  Google Scholar 

  48. Palecek J, Paleckova V, Dougherty PM, Carlton SM, Willis WD (1992) Responses of spinothalamic tract cells to mechanical and thermal stimulation of the skin in rats with an experimental peripheral neuropathy. J Neurophysiol 67:1562–1573

    CAS  PubMed  Google Scholar 

  49. Parnet P, Kelley KW, Bluthe RM, Dantzer R (2002) Expression and regulation of interleukin-1 receptors in the brain. Role of cytokines-induced sickness behavior. J Neuroimmunol 125:5–14

    Article  CAS  PubMed  Google Scholar 

  50. Perkins BA, Olaleye D, Zinman B, Bril V (2001) Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care 24:250–255

    CAS  PubMed  Google Scholar 

  51. Pogrebniak HW, Matthews W, Pass HI (1991) Chemotherapy amplifies production of tumor necrosis factor. Surgery 110:231–237

    CAS  PubMed  Google Scholar 

  52. Postma TJ, Benard BA, Huijgens PC, Ossenkoppele GJ, Heimans JJ (1993) Long term effects of vincristine on the peripheral nervous system. J Neurooncol 15:23–27

    CAS  PubMed  Google Scholar 

  53. Rajkumar SV, Fonseca R, Witzig TE (2001) Complete resolution of reflex sympathetic dystrophy with thalidomide treatment. Arch Intern Med 161:2502–2503

    Article  CAS  PubMed  Google Scholar 

  54. Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre J, Woolf CJ (2001) Interleukin-1b-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410:471–475

    Article  CAS  PubMed  Google Scholar 

  55. Sampaio EP, Sarno EN, Galilly R, Cohn AZ, Kaplan G (1991) Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med 173:699–703

    Article  CAS  PubMed  Google Scholar 

  56. Sandler SG, Tobin W, Henderson ES (1969) Vincristine-induced neuropathy. A clinical study of fifty leukemic patients. Neurology 19:367–374

    CAS  PubMed  Google Scholar 

  57. Schäfers M, Svensson CI, Sommer C, Sorkin LS (2003) Tumor necrosis factor-a induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci 23:2517–2521

    PubMed  Google Scholar 

  58. Seltzer Z, Dubner R, Shir Y (1990) A novel behavioral model of neuropathic pain disorders produced by partial sciatic nerve injury. Pain 43:205–218

    Article  CAS  PubMed  Google Scholar 

  59. Shelanski ML, Wisniewski K (1969) Neurofibrillary degeneration. Arch Neurol 20:199–206

    CAS  PubMed  Google Scholar 

  60. Singh RK, Sodhi A, Singh SM (1991) Production of interleukin-1 and tumor necrosis factor by cisplatin- treated murine peritoneal macrophages. Nat Immun Cell Growth Regul 10:105–116

    CAS  PubMed  Google Scholar 

  61. So YT, Holtzman D, Abrams DI, Olney KO (1988) Peripheral neuropathy associated with acquired immunodeficiency syndrome. Arch Neurol 45:945–948

    CAS  PubMed  Google Scholar 

  62. Sodhi A, Pai K (1992) Increased production of interleukin-1 and tumor necrosis factor by human monocytes treated in vitro with cisplatin or other biological response modifiers. Immunol Lett 34:183–188

    Article  CAS  PubMed  Google Scholar 

  63. Sommer C, Marziniak M, Myers RR (1998) The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve. Pain 74:83–91

    Article  CAS  PubMed  Google Scholar 

  64. Sorkin LS, Doom CM (2000) Epineurial application of TNF elicits an acute mechanical hyperalgesia in the awake rat. J Peripher Nerv Syst 5:96–100

    Article  CAS  PubMed  Google Scholar 

  65. Sorkin LS, Xaio W-H, Wagner R, Myers RR (1997) Tumour necrosis factor-a induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 81:255–262

    Article  CAS  PubMed  Google Scholar 

  66. Subbaramaiah K, Hart JC, Norton L, Dannenberg JA (2000) Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. J Biol Chem 275:14838–14845

    Article  CAS  PubMed  Google Scholar 

  67. Svensson CI, Yaksh TL (2002) The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. Annu Rev Pharmacol Toxicol 42:553–583

    Article  CAS  PubMed  Google Scholar 

  68. Swiergiel AH, Dunn AJ (2002) Distinct roles for cyclooxygenases 1 and 2 in interleukin-1-induced behavioral changes. J Pharmacol Exp Ther 302:1031–1036

    Article  CAS  PubMed  Google Scholar 

  69. Syriatowicz J-P, Hu D, Walker JS, Tracey DJ (1999) Hyperalgesia due to nerve injury: role of prostaglandins. Neuroscience 94:587–594

    Article  CAS  PubMed  Google Scholar 

  70. Tanner KD, Levine JD, Topp KS (1998) Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine-induced painful neuropathy in rat. J Comp Neurol 395:481–492

    Article  CAS  PubMed  Google Scholar 

  71. Tanner KD, Reichling DB, Levine JD (1998) Nociceptor hyper-responsiveness during vincristine-induced painful peripheral neuropathy in the rat. J Neurosci 18:6480–6491

    CAS  PubMed  Google Scholar 

  72. Watkins LR, Wiertelak EP, Goehler LE, Mooney-Heiberger K, Martinez J, Furness L, Smith KP, Maier SF (1994) Neurocircuitry of illness-induced hyperalgesia. Brain Res 639:283–299

    Article  CAS  PubMed  Google Scholar 

  73. Watkins LR, Wiertelak EP, Goehler LE, Smith KP, Martin D, Maier SF (1994) Characterization of cytokine-induced hyperalgesia. Brain Res 654:15–26

    Article  CAS  PubMed  Google Scholar 

  74. Weiss HD, Walker MD, Wiernik PH (1974) Neurotoxicity of commonly used antineoplastic agents. N Engl J Med 291:127–133

    CAS  PubMed  Google Scholar 

  75. Weng H-R, Cordella JV, Dougherty PM (2002) Changes in sensory processing in the spinal dorsal horn accompany vincristine-induced hyperalgesia and allodynia. Pain 103:131–138

    Article  Google Scholar 

  76. Wiertelak EP, Smith KP, Furness L, Mooney-Heiberger K, Mayr T, Maier SF, Watkins LR (1994) Acute hyperalgesic responses to illness. Pain 56:227–234

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Symptom Research, The Division of Anesthesiology and Critical Care Medicine, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., P.O. Box 42, Houston, TX 77030, USA

    J. P. Cata, H.-R. Weng & P. M. Dougherty

Authors
  1. J. P. Cata
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H.-R. Weng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. M. Dougherty
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. M. Dougherty.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cata, J.P., Weng, HR. & Dougherty, P.M. Cyclooxygenase inhibitors and thalidomide ameliorate vincristine-induced hyperalgesia in rats. Cancer Chemother Pharmacol 54, 391–397 (2004). https://doi.org/10.1007/s00280-004-0809-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-004-0809-y

Keywords

Search

Navigation